We are live on ! Find out more
BRTX icon

BioRestorative Therapies
BRTX

13 hedge funds and large institutions have $502K invested in BioRestorative Therapies in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

16% more capital inflows, than outflows

Capital inflows: $53.2K | Capital outflows: $46K

0.02% less ownership

Funds ownership: 4.1% → 4.07% (-0.02%)

7% less funds holding

Funds holding: 14 → 13 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$20.1K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$17.7K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$10.1K
4
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$3.1K
5
SG
StoneX Group
New York
+$2.03K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$30.7K
2
UBS Group
UBS Group
Switzerland
-$15.3K

BRTX Hedge Fund Activity: Q1 2025 in Review

13 of the 7,478 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q1 2025, worth a combined $502K — up 24% from $406K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BRTX and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 6 added.

The largest buyer was Morgan Stanley, adding an estimated $20.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $30.7K sold.

  • 13 institutional investors held BioRestorative Therapies (BRTX) as of Q1 2025, down from 14 in Q4 2024.
  • Funds reported $502K of BioRestorative Therapies stock for Q1 2025, up 24% quarter-over-quarter.
  • 0 funds opened new BioRestorative Therapies positions in Q1 2025 and 1 closed out, a net change of -1 holder.
  • The largest BioRestorative Therapies buyer in Q1 2025 was Morgan Stanley, an estimated $20.1K added.
  • The largest BioRestorative Therapies seller in Q1 2025 was Citadel Advisors, an estimated $30.7K sold.

Based on aggregated 13F filings for Q1 2025.